| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 758 | 2012 |
| Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. TS Frank, SA Manley, OI Olopade, S Cummings, JE Garber, B Bernhardt, ... Journal of Clinical Oncology 16 (7), 2417-2425, 1998 | 593 | 1998 |
| BRCAPRO Validation, Sensitivity of Genetic Testing of BRCA1/BRCA2, and Prevalence of Other Breast Cancer Susceptibility Genes DA Berry, ES Iversen Jr, DF Gudbjartsson, EH Hiller, JE Garber, ... Journal of Clinical Oncology 20 (11), 2701-2712, 2002 | 574 | 2002 |
| BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing D Shattuck-Eidens, A Oliphant, M McClure, C McBride, J Gupte, T Rubano, ... Jama 278 (15), 1242-1250, 1997 | 507 | 1997 |
| Characterization of BRCA1 and BRCA2 mutations in a large United States sample S Chen, ES Iversen, T Friebel, D Finkelstein, BL Weber, A Eisen, ... Journal of clinical oncology: official journal of the American Society of …, 2006 | 418 | 2006 |
| Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families P Tonin, B Weber, K Offit, F Couch, TR Rebbeck, S Neuhausen, ... Nature medicine 2 (11), 1179-1183, 1996 | 394 | 1996 |
| A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. D Cella, C Hughes, A Peterman, CH Chang, BN Peshkin, MD Schwartz, ... Health Psychology 21 (6), 564, 2002 | 322 | 2002 |
| Impact of BRCA1/BRCA2 Counseling and Testing on Newly Diagnosed Breast Cancer Patients MD Schwartz, C Lerman, B Brogan, BN Peshkin, C Hughes Halbert, ... Journal of Clinical Oncology 22 (10), 1823-1829, 2004 | 319 | 2004 |
| Impact of BRCA1/BRCA2 Mutation Testing on Psychologic Distress in a Clinic-Based Sample MD Schwartz, BN Peshkin, C Hughes, D Main, C Isaacs, C Lerman Journal of clinical oncology 20 (2), 514-520, 2002 | 312 | 2002 |
| Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses H Zhang, TU Ahearn, J Lecarpentier, D Barnes, J Beesley, G Qi, X Jiang, ... Nature genetics 52 (6), 572-581, 2020 | 305 | 2020 |
| Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer MD Schwartz, HB Valdimarsdottir, BN Peshkin, J Mandelblatt, R Nusbaum, ... Journal of Clinical Oncology 32 (7), 618, 2014 | 281 | 2014 |
| All in the family: Evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results C Hughes, C Lerman, M Schwartz, BN Peshkin, L Wenzel, S Narod, ... American journal of medical genetics 107 (2), 143-150, 2002 | 260 | 2002 |
| BRCA1/2 mutations and triple negative breast cancers BN Peshkin, ML Alabek, C Isaacs Breast disease 32 (1-2), 25-33, 2011 | 210 | 2011 |
| Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: The contributions of personality and appraisal, J Audrain, MD Schwartz, C Lerman, C Hughes, BN Peshkin, B Biesecker Annals of behavioral medicine 19 (4), 370-377, 1997 | 176 | 1997 |
| Validity of Models for Predicting BRCA1 and BRCA2 Mutations G Parmigiani, S Chen, ES Iversen Jr, TM Friebel, DM Finkelstein, ... Annals of internal medicine 147 (7), 441-450, 2007 | 164 | 2007 |
| Long‐term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance MD Schwartz, C Isaacs, KD Graves, E Poggi, BN Peshkin, C Gell, C Finch, ... Cancer 118 (2), 510-517, 2012 | 162 | 2012 |
| Bilateral Prophylactic Oophorectomy and Ovarian Cancer Screening Following BRCA1/BRCA2 Mutation Testing MD Schwartz, E Kaufman, BN Peshkin, C Isaacs, C Hughes, T DeMarco, ... Journal of Clinical Oncology 21 (21), 4034-4041, 2003 | 157 | 2003 |
| Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes L Fachal, H Aschard, J Beesley, DR Barnes, J Allen, S Kar, KA Pooley, ... Nature genetics 52 (1), 56-73, 2020 | 149 | 2020 |
| Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis X Zhang, HC Chiang, Y Wang, C Zhang, S Smith, X Zhao, SJ Nair, ... Nature communications 8 (1), 15908, 2017 | 147 | 2017 |
| What would you do? Specialists’ perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination ET Matloff, H Shappell, K Brierley, BA Bernhardt, W McKinnon, ... Journal of clinical oncology 18 (12), 2484-2492, 2000 | 147 | 2000 |
